XML 16 R6.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Other Comprehensive Income
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2018   52,477,593      
Beginning balance at Dec. 31, 2018 $ 275,422 $ 52 $ 611,587 $ 1 $ (336,218)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock form the exercise of stock options and settlement of restricted stock units (in shares)   485,083      
Issuance of common stock from the exercise of stock options and settlement of restricted stock units 179 $ 1 178    
Stock-based compensation expense 3,282   3,282    
Net income (loss) (612)       (612)
Other comprehensive income (loss), net of tax 134     134  
Ending balance (in shares) at Mar. 31, 2019   52,962,676      
Ending balance at Mar. 31, 2019 278,405 $ 53 615,047 135 (336,830)
Beginning balance (in shares) at Dec. 31, 2018   52,477,593      
Beginning balance at Dec. 31, 2018 275,422 $ 52 611,587 1 (336,218)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 111,337        
Other comprehensive income (loss), net of tax 210        
Ending balance (in shares) at Sep. 30, 2019   53,333,211      
Ending balance at Sep. 30, 2019 400,907 $ 53 625,524 211 (224,881)
Beginning balance (in shares) at Mar. 31, 2019   52,962,676      
Beginning balance at Mar. 31, 2019 278,405 $ 53 615,047 135 (336,830)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock form the exercise of stock options and settlement of restricted stock units (in shares)   302,108      
Issuance of common stock from the exercise of stock options and settlement of restricted stock units 3,411 $ 0 3,411    
Stock-based compensation expense 3,101   3,101    
Net income (loss) 11,526       11,526
Other comprehensive income (loss), net of tax 251     251  
Ending balance (in shares) at Jun. 30, 2019   53,264,784      
Ending balance at Jun. 30, 2019 296,694 $ 53 621,559 386 (325,304)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock form the exercise of stock options and settlement of restricted stock units (in shares)   68,427      
Issuance of common stock from the exercise of stock options and settlement of restricted stock units 558 $ 0 558    
Stock-based compensation expense 3,407   3,407    
Net income (loss) 100,423       100,423
Other comprehensive income (loss), net of tax (175)     (175)  
Ending balance (in shares) at Sep. 30, 2019   53,333,211      
Ending balance at Sep. 30, 2019 $ 400,907 $ 53 625,524 211 (224,881)
Beginning balance (in shares) at Dec. 31, 2019 53,549,612 53,549,612      
Beginning balance at Dec. 31, 2019 $ 410,945 $ 54 631,307 249 (220,665)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock form the exercise of stock options and settlement of restricted stock units (in shares)   582,724      
Issuance of common stock from the exercise of stock options and settlement of restricted stock units 479 $ 0 479    
Stock-based compensation expense 3,944   3,944    
Net income (loss) 486       486
Other comprehensive income (loss), net of tax 532     532  
Ending balance (in shares) at Mar. 31, 2020   54,132,336      
Ending balance at Mar. 31, 2020 $ 416,386 $ 54 635,730 781 (220,179)
Beginning balance (in shares) at Dec. 31, 2019 53,549,612 53,549,612      
Beginning balance at Dec. 31, 2019 $ 410,945 $ 54 631,307 249 (220,665)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 15,147        
Other comprehensive income (loss), net of tax $ 130        
Ending balance (in shares) at Sep. 30, 2020 54,689,654 54,689,654      
Ending balance at Sep. 30, 2020 $ 440,572 $ 55 645,656 379 (205,518)
Beginning balance (in shares) at Mar. 31, 2020   54,132,336      
Beginning balance at Mar. 31, 2020 416,386 $ 54 635,730 781 (220,179)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock form the exercise of stock options and settlement of restricted stock units (in shares)   496,000      
Issuance of common stock from the exercise of stock options and settlement of restricted stock units 3,600 $ 1 3,599    
Stock-based compensation expense 3,069   3,069    
Net income (loss) 8,714       8,714
Other comprehensive income (loss), net of tax (185)     (185)  
Ending balance (in shares) at Jun. 30, 2020   54,628,336      
Ending balance at Jun. 30, 2020 431,584 $ 55 642,398 596 (211,465)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock form the exercise of stock options and settlement of restricted stock units (in shares)   61,318      
Issuance of common stock from the exercise of stock options and settlement of restricted stock units 123 $ 0 123    
Stock-based compensation expense 3,135   3,135    
Net income (loss) 5,947       5,947
Other comprehensive income (loss), net of tax $ (217)     (217)  
Ending balance (in shares) at Sep. 30, 2020 54,689,654 54,689,654      
Ending balance at Sep. 30, 2020 $ 440,572 $ 55 $ 645,656 $ 379 $ (205,518)